Siemens Healthcare recently presented its first MRI breast scanner, Magnetom Espree-Pink.
This 1.5-Tesla system is the latest innovation in magnetic resonance imaging (MRI) from Siemens, featuring a dedicated solution for breast examinations. Particularly for obese and claustrophobic patients, the large, 70-centimeter magnet bore makes examinations more comfortable than with previous systems, or, in some cases, it makes them possible for the first time ever. The flexible design of the "Sentinelle Vanguard for Siemens" breast coil also optimizes the clinical workflow. Comprehensive applications, such as syngo Grace or syngo Views, additionally set a new standard in Women’s Health.
At almost 30 percent, breast cancer is the most common form of cancer occurring among women in Germany, as well as throughout Europe. Approximately 57,000 women annually develop breast cancer in Germany; 17,500 women per year die from breast cancer1. The American National Cancer Institute estimates that a woman has a 1-in-8 chance of developing breast cancer during her lifetime. The American Cancer Society’s new screening guidelines will impact up to 1.4 million high-risk women by recommending they receive annual MRI screenings.2 A high percentage of these women will benefit from breast MRI.
Siemens developed the Magnetom Espree-Pink specifically for breast scans and to make examinations more comfortable for patients due to its compact, open design. With a diameter of 70 centimeters, the magnet bore is 10 centimeters wider than most conventional systems. Furthermore, with 125 centimeters, the Magnetom Espree-Pink is the shortest system available on the market. Patients can be positioned either feet-first or head-first, according to requirements. The design of the Magnetom Espree-Pink is an enormous advantage for patients who feel confined by the spatial constrictions of previous MRI systems. Moreover, the scanner also offers sufficient space for adipose patients. “Patients are always nervous during breast MRI examinations and biopsies. The biggest advantage in using Magnetom Espree and the Sentinelle system is the wide open access,” said Jae K. Kim, MD, PhD, Radiology Limited, Tuscon, Arizona.
The flexible "Sentinelle Vanguard for Siemens" coil solution makes both imaging and biopsies possible using only a single coil. Depending on requirements, only the lateral inserts of the coil are replaced. The frame itself remains on the table and does not have to be repositioned. In addition, due to its variable coil geometry (VCG), the coil can be optimally adapted to the different breast sizes of various patients. Excellent image quality is attained through an improved signal-to-noise ratio and with the help of eight RF channels.
"One important component of the new system is the ‘Sentinelle Vanguard for Siemens’ breast coil, which can be used flexibly to optimize workflows. The customer benefits from excellent image quality, optimized biopsy access with improved accuracy, and short examination times, which enable a higher patient throughput," said Walter Märzendorfer, CEO of Magnetic Resonance Imaging at Siemens Healthcare.
The new system additionally offers a comprehensive range of standard and advanced applications for breast imaging. These include, among others, the Breast Suite with Syngo Views for routine examination requirements, which can be used to obtain a three-dimensional representation of the breast with a high spatial and high temporal resolution in the sub-millimeter range, for instance.
Syngo Grace is an application package for quantitative MR breast spectroscopy. This software can display the biomarker choline, thus providing valuable information on the biochemical composition of breast lesions. Syngo Blade is an application that ensures motion-free images, even when the patient moves during the examination.
The workstation of the Magnetom Espree-Pink is equipped with the new syngo BreVis and syngo BreVis Biopsy software applications for planning and running the individual work steps during the image acquisition and biopsy processes. For example, syngo BreVis enables clinicians to prepare reports, calculate the size of a lesion, or compare MRI results with ultrasound or X-ray mammography images. The syngo BreVis Biopsy software application supports the physician in performing biopsies accurately and quickly using automatic calculations and pre-settings.
The system is equipped with 18 channels, which ensures its investment security. The breast scanner can be upgraded to a Magnetom Espree with all imaging possibilities for any anatomical region, if required.
The Siemens Healthcare Sector is one of the largest suppliers of healthcare technology in the world. The company sees itself as a medical solution provider with key competences and innovative strength in diagnostic and therapeutic technologies as well as in knowledge processing including IT and system integration. With its acquisitions in laboratory diagnostics, Siemens Healthcare is the first integrated healthcare company that combines imaging and lab diagnostics, therapy solutions and medical information technology and also supplements these with consultation and services. Siemens Healthcare offers solutions for the entire supply chain under one roof - from prevention and early detection to diagnosis and on to treatment and aftercare. In addition, Siemens Healthcare is the global market leader for innovative hearing aids. The company employs some 49,000 employees worldwide and is present in more than 130 countries. During fiscal 2008 (ending on September 30), Siemens Healthcare achieved sales of 11.17 billion euros and incoming orders totaling 11.78 billion euros. The Sector profit from operations amounted to 1.23 billion euros.
1 Federal Ministry for Health "Mammography screening in Germany – experiences and perspectives", ddb-forum Berlin, April 2008
2 Global Cancer Facts and Figures 2007
Bianca Braun | Siemens Healthcare
Virtual Reality in Medicine: New Opportunities for Diagnostics and Surgical Planning
07.12.2016 | Universität Basel
3-D printed kidney phantoms aid nuclear medicine dosing calibration
06.12.2016 | Society of Nuclear Medicine
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
08.12.2016 | Life Sciences
08.12.2016 | Physics and Astronomy
08.12.2016 | Materials Sciences